HEMOCHROMATOSIS SCREENING IN ASYMPTOMATIC AMBULATORY MEN 30 YEARS OF AGE AND OLDER

被引:89
作者
BAER, DM [1 ]
SIMONS, JL [1 ]
STAPLES, RL [1 ]
RUMORE, GJ [1 ]
MORTON, CJ [1 ]
机构
[1] KAISER PERMANENTE MED CTR,DEPT PATHOL,OAKLAND,CA 94611
关键词
D O I
10.1016/S0002-9343(99)80346-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: TO perform a cost-benefit analysis of screening for hereditary hemochromatosis. PATIENTS AND METHODS: A total of 3,977 consecutive men greater than or equal to 30 years of age who presented for routine health checkups at a HEALTH maintenance organization medical center were screened for hereditary hemochromatosis by measuring transferrin saturation. Subjects with repeated transferrin saturation greater than or equal to 62% and ferritin level greater than or equal to 500 ng/mL (greater than or equal to 500 mu g/L) were referred for liver biopsy. Subjects with transferrin saturation <15% were referred for evaluation. Laboratory testing, screening, and abnormal screening test evaluation procedures were identified by chart review. RESULTS: Forty patients had transferrin saturation greater than or equal to 62%. One hundred seventy-two had transferrin saturation <15%. Eight patients with hemochromatosis were identified. The 3 patients most seriously affected had hepatic iron concentrations >250 mu mol/g dry weight. Two of them had hepatic fibrosis. Seven cases of hemochromatosis were found among 1,974 white subjects who were screened. Only 1 case was found among the remaining subjects. CONCLUSIONS: Our observations support routine screening with transferrin saturation for white men greater than or equal to 30 years of age.
引用
收藏
页码:464 / 468
页数:5
相关论文
共 29 条
  • [1] Adams P C, 1989, Adv Intern Med, V34, P111
  • [2] LONG-TERM SURVIVAL ANALYSIS IN HEREDITARY HEMOCHROMATOSIS
    ADAMS, PC
    SPEECHLEY, M
    KERTESZ, AE
    [J]. GASTROENTEROLOGY, 1991, 101 (02) : 368 - 372
  • [3] VALUE OF HEPATIC IRON MEASUREMENTS IN EARLY HEMOCHROMATOSIS AND DETERMINATION OF THE CRITICAL IRON LEVEL ASSOCIATED WITH FIBROSIS
    BASSETT, ML
    HALLIDAY, JW
    POWELL, LW
    [J]. HEPATOLOGY, 1986, 6 (01) : 24 - 29
  • [4] BORWEIN ST, 1983, CLIN INVEST MED, V6, P171
  • [5] HEMOCHROMATOSIS - CURRENT CONCEPTS AND MANAGEMENT
    CROSBY, WH
    [J]. HOSPITAL PRACTICE, 1987, 22 (02): : 173 - &
  • [6] LIVER PATHOLOGY IN GENETIC HEMOCHROMATOSIS - A REVIEW OF 135 HOMOZYGOUS CASES AND THEIR BIOCLINICAL CORRELATIONS
    DEUGNIER, YM
    LOREAL, O
    TURLIN, B
    GUYADER, D
    JOUANOLLE, H
    MOIRAND, R
    JACQUELINET, C
    BRISSOT, P
    [J]. GASTROENTEROLOGY, 1992, 102 (06) : 2050 - 2059
  • [7] EDWARDS CQ, 1993, NEW ENGL J MED, V328, P1616
  • [8] PREVALENCE OF HEMOCHROMATOSIS AMONG 11,065 PRESUMABLY HEALTHY BLOOD-DONORS
    EDWARDS, CQ
    GRIFFEN, LM
    GOLDGAR, D
    DRUMMOND, C
    SKOLNICK, MH
    KUSHNER, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (21) : 1355 - 1362
  • [9] FAIRBANKS VF, 1991, HOSP PRACT, V26, P17
  • [10] SURVIVAL AND PROGNOSTIC FACTORS IN 212 ITALIAN PATIENTS WITH GENETIC HEMOCHROMATOSIS
    FARGION, S
    MANDELLI, C
    PIPERNO, A
    CESANA, B
    FRACANZANI, AL
    FRAQUELLI, M
    BIANCHI, PA
    FIORELLI, G
    CONTE, D
    [J]. HEPATOLOGY, 1992, 15 (04) : 655 - 659